Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression - PubMed (original) (raw)
Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression
S Koenig et al. Nat Med. 1995 Apr.
Abstract
An HIV-1-seropositive volunteer was infused with an expanded autologous cytotoxic T lymphocyte (CTL) clone directed against the HIV-1 nef protein. This clone was adoptively transferred to determine whether supplementing CTL activity could reduce viral load or improve clinical course. Unexpectedly, infusion was followed by a decline in circulating CD4+ T cells and a rise in viral load. Some of the HIV isolates obtained from the plasma or CD4+ cells of the patient were lacking the nef epitope. These results suggest that active CTL selection of viral variants could contribute to the pathogenesis of AIDS and that clinical progression can occur despite high levels of circulating HIV-1-specific CTLs.
Comment in
- CTL to HIV-1: surrogates or sirens.
Mathieson BJ. Mathieson BJ. Nat Med. 1995 Apr;1(4):304-5. doi: 10.1038/nm0495-304. Nat Med. 1995. PMID: 7585057 No abstract available.
Similar articles
- A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
Singh MK, Janvier G, Calvez V, Coulaud P, Rivière Y. Singh MK, et al. AIDS Res Hum Retroviruses. 2001 Sep 1;17(13):1265-71. doi: 10.1089/088922201750461320. AIDS Res Hum Retroviruses. 2001. PMID: 11559426 - Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients.
Legrand E, Pellegrin I, Neau D, Pellegrin JL, Ragnaud JM, Dupon M, Guillemain B, Fleury HJ. Legrand E, et al. AIDS Res Hum Retroviruses. 1997 Nov 1;13(16):1383-94. doi: 10.1089/aid.1997.13.1383. AIDS Res Hum Retroviruses. 1997. PMID: 9359658 - Development of HIV-1 Nef vaccine components: immunogenicity study of Nef mutants lacking myristoylation and dileucine motif in mice.
Liang X, Fu TM, Xie H, Emini EA, Shiver JW. Liang X, et al. Vaccine. 2002 Sep 10;20(27-28):3413-21. doi: 10.1016/s0264-410x(02)00308-0. Vaccine. 2002. PMID: 12213412 - [The immunology of the infection caused by the human immunodeficiency virus].
Hollan S. Hollan S. Zh Mikrobiol Epidemiol Immunobiol. 1989 Oct;(10):21-7. Zh Mikrobiol Epidemiol Immunobiol. 1989. PMID: 2575312 Review. Russian. - Modeling AIDS in a mouse.
Mosier DE. Mosier DE. Hosp Pract (1995). 1996 Sep 15;31(9):41-8, 53-5, 59-60. doi: 10.1080/21548331.1996.11443344. Hosp Pract (1995). 1996. PMID: 8814120 Review.
Cited by
- Single-cycle influenza virus vaccine generates lung CD8+ Trm that cross-react against viral variants and subvert virus escape mutants.
Zheng MZM, Tan TK, Villalon-Letelier F, Lau H, Deng YM, Fritzlar S, Valkenburg SA, Gu H, Poon LLM, Reading PC, Townsend AR, Wakim LM. Zheng MZM, et al. Sci Adv. 2023 Sep 8;9(36):eadg3469. doi: 10.1126/sciadv.adg3469. Epub 2023 Sep 8. Sci Adv. 2023. PMID: 37683004 Free PMC article. - CCR5∆32 and SDF1 3'A: Gene Variants, Expression and Influence on Biological Markers for the Clinical Progression to AIDS among HIV-1 Virus Controllers in a Mixed Population of the Amazon Region of Brazil.
Lima ÉRG, Queiroz MAF, Lima SS, Machado LFA, Cayres-Vallinoto IMV, Vallinoto ACR, Figueiredo FAPL, Guerreiro JF, Guimarães Ishak MO, Ishak R. Lima ÉRG, et al. Int J Mol Sci. 2023 Mar 4;24(5):4958. doi: 10.3390/ijms24054958. Int J Mol Sci. 2023. PMID: 36902388 Free PMC article. - Pathogen-specific T Cells: Targeting Old Enemies and New Invaders in Transplantation and Beyond.
Papadopoulou A, Alvanou M, Karavalakis G, Tzannou I, Yannaki E. Papadopoulou A, et al. Hemasphere. 2023 Jan 9;7(1):e809. doi: 10.1097/HS9.0000000000000809. eCollection 2023 Jan. Hemasphere. 2023. PMID: 36698615 Free PMC article. Review. - Combination strategies to durably suppress HIV-1: Soluble T cell receptors.
Wallace Z, Singh PK, Dorrell L. Wallace Z, et al. J Virus Erad. 2022 Aug 24;8(3):100082. doi: 10.1016/j.jve.2022.100082. eCollection 2022 Sep. J Virus Erad. 2022. PMID: 36065296 Free PMC article. - Sustainable Antiviral Efficacy of Rejuvenated HIV-Specific Cytotoxic T Lymphocytes Generated from Induced Pluripotent Stem Cells.
Miki S, Kawai Y, Nakayama-Hosoya K, Iwabuchi R, Terahara K, Tsunetsugu-Yokota Y, Koga M, Matano T, Kaneko S, Kawana-Tachikawa A. Miki S, et al. J Virol. 2022 Mar 23;96(6):e0221721. doi: 10.1128/jvi.02217-21. Epub 2022 Feb 2. J Virol. 2022. PMID: 35107374 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials